Adaptation and validation of the spanish version of the quality of life in latex allergy questionnaire (QOLLA)

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 4, 2011, Pages 283-289

  Dieguez M C ^a   Cerecedo, I ^a   Muriel, A ^b   Losada, A ^c   Garcia E ^d   Lazaro M ^e   de la Hoz, B ^b  

^a Hospital Universitario del Sureste de Madrid   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c Hospital de Parla   (Spain)

^d Asociación Española de Personas con Alergia a Alimentos y Látex AEPNAA   (Spain)

^e Clinica Alergoasma   (Spain)

Author keywords

Adaptation; Latex allergy; Quality of life; Questionnaire; Spanish; Validation

Indexed keywords

LATEX;

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; CONSTRUCT VALIDITY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HUMAN; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; MALE; MENTAL FUNCTION; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; QUALITY OF LIFE IN LATEX ALLERGY QUESTIONNAIRE; QUESTIONNAIRE; SCORING SYSTEM; VALIDATION PROCESS; VISUAL ANALOG SCALE;

ADULT; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; LANGUAGE; LATEX HYPERSENSITIVITY; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPAIN; YOUNG ADULT;

EID: 79959392664     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Slater J. Rubber anaphylaxis. N Eng J Med. 1989;320:626-31.
2. Task force on allergic reactions to latex. Committee report. J Allergy Clin Immunol. 1993;92:16-37.
3. Cohen D, Scheman A, Stewart L, Taylor J, Pratt M, Trotter K, Prawer S, Warshaw E, Rietschel R, Watsky K, Schwarzenberger K, Zug K, Shama S, Godwin L, Kosann MK, Wilson BA. American Academy of Dermatology ́s position paper on latex allergy. J Am Acad Dermatol. 1998;39:99-105.
4. Hunt LW, Fransway AF, Reed CE, Miller LK, Jones RT, Swanson MC Yunginger JW. An epidemic of occupational allergy to latex involving health care workers. J Occup Environ Med. 1995;37(10):1204-9.
5. Liss GM, Sussman GL, Deal K, Brown S, Cividino M, Siu Beezhold DH, Smith G, Swanson MC, Yunginger J, Douglas A, Holness DL, Lebert P, Keith P, Wasserman S, Turjanmaa K. Latex allergy: epidemiological study of 1351 hospital workers. Occup Environ Med. 1997;54(5):335-42.
6. Yassin MS, Lierl MB, Fischer TJ, O'Brien K, Cross J, Steinmetz C. Latex allergy in hospital employees. Ann Allergy. 1994;72:245-9.
7. Van der Valle HB, Brunsveld VM. Latex allergy among hairdressers. Contact Dermatitis. 1995; 32: 177-8
8. Konz KR, Chia JK, Kurup VP, Resnick A, Kelly KJ, Fink JN. Comparison of latex hypersensitivity among patients with neurologic defects. J Allergy Clin Immunol. 1995;95:950-4.
9. Estornell F, Nieto A, Mazón A, Reig C, Martínez M, Dominguez C, García-Ibarra F. Alergia al látex en niños con mielomeningocele. Incidencia y factores asociados. Actas Urol Esp. 1997;21(3):227-35.
10. Nakamura CT, Ferdman RM, Keens TG, Ward SL, Davidson M. Latex Allergy in Children on Home Mechanical Ventilation. Chest. 2000;118(4):1000-3.
11. Moneret-Vautrin DA, Beaudouin E, Widmer S, Mouton C, Kanny G, Prestat F, Kohler C, Feldmann L. Prospective study of risk factors,in natural rubber latex hypersensitivity. J Allergy Clin Immunol. 1993;92:668-77.
12. Blanco C, Quirce S. Alergia al látex. Barcelona: mra ediciones; 2002.
13. Turjanmaa K. Allergy to natural rubber latex: a growing problem. Ann Med. 1994;26:297-300.
14. Sánchez Fernández C, Quirce S, Sánchez Cano M. Preoperative screening for general anesthesia. Allergy. 1998;5:542-3.
15. Turjanmaa K. Incidence of immediate allergy to latex gloves in hospital personnel. Contact Dermatitis. 1987;17:270-5.
16. Vila L, Sánchez G, Año M, Uasuf CG, Sanz ML. Risk factors for latex sensitization among health care workers. J Investig Allergol Clin Immunol. 1999;9:356-60.
17. Nutter AF. Contact urticaria to rubber. Br J Dermatol. 1979;101:597-8.
18. Slater JE. Rubber anaphylaxis. N Engl J Med 1989; 320: 1126-30.
19. Spaner D, Dolovich J, Tarlo S, Sussman G, Buttoo K. Hypersensitivity to natural latex. J Allergy Clin Immunol 1989; 83: 1135-7.
20. Charous B, Blanco C, Tarlo S, Hamilton RG, Baur X, Beezhold D, Sussman G, Yunginguer JW. Natural rubber latex allergy after 12 years: Recommendations and perspectives. JACI. 2002;109:31-4.
21. Tabar AI, Anda M, Bonifazi F, Bilo MB, Leynadier F, Fuchs T, Ring J, Galvain S, Andre C. Specifi c Immunotherapy with Standardized Latex Extract versus Placebo in Latex-Allergic Patients. Int Arch Allergy Immunol. 2006 Aug 30;141(4):369-76.
22. Bernardini R, Campodonico P, Burastero S, Azzari C, Novembre E, Pucci N, Massai C, De Martino M, Vierucci A. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebocontrolled study. Curr Med Res Opin. 2006 Aug;22(8):1515-22.
23. Sastre J, Quirce S. Immunotherapy: an option in the management of occupational asthma? Curr Opin Allergy Clin Immunol. 2006 Apr;6(2):96-100.
24. Leynadier F, Doudou O, Gaouar H, Le Gros V, Bourdeix I, Guyomarch-Cocco L, Trunet P. Effect of omalizumab in health care workers with occupational latex allergy. J Allergy Clin Immunol. 2004 Feb;113(2):360-1.
25. Ylitalo L, Alenius H, Turjanmaa K, Palosuo T, Reunala T. Natural rubber latex allergy in children: a follow up study. Clin Exp Allergy. 2000;30:1611-7.
26. Diéguez MC, Antón M, Blanco R, Pulido Z, Muriel A, de la Hoz B. Latex allergy in childhood: a follow up study. Allergol et Immunopathol. 2006; 34(1): 17-22.
27. Lewis-Jones MS, Dawe RS, Lowe JG. Quality of life of children with type 1 latex allergy and their parents: use and primary validation of the QoLLA-C and QoLLA-P questionnaires. Br J Dermatol 2005; 153 (Suppl. 1):83-4.
28. Lewis-Jones MS, Dawe RS, Lowe JG. Quality of life of patients with type 1 latex allergy: use and primary validation of the QoLLA questionnaire. Abstracts for the British Association of Dermatologists 85th Annual Meeting, Glasgow, United Kingdom, 5-8 July 2005. Br J Dermatol. 2005 Jul;153 Suppl 1:1-98.
29. Guyatt G, Feeny D, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622-9.
30. Badia X, Salamero M, Alonso J, Ollé A. La medida de la salud: guía de escalas de medición en español. Barcelona: PPU; 1996.
31. Soler R, De la Hoz B, Badiac X, Mercadale J, Lozano R, Benavides A, Roset M, en nombre del Grupo Carino. Validación de la versión española del cuestionario de calidad de vida para pacientes con rinoconjuntivitis. Rev Clin Esp. 2004;204(3):131-8.
32. Guillemin F, Bombardier C, Beaton S. Cross-cultural adaption of healthrelated quality of life measures: literature review and proposed guidelines. J Clin Epidemiol. 1993;12:417-32.
33. Laforest L, Bousquet J, Pietri G, Sazonov Kocevar V, Yin D, Pacheco Y, Van Ganse E. Quality of life during pollen season in patients with seasonal allergic rhinitis with or without asthma. Int Arch Allergy Immunol. 2005;136:281-6.
34. Kiebert G, Sorensen SV, Revicki D, Fagan SC, Doyle JJ, Cohen J, Fivenson D. Atopic dermatitis is associated with a decrement in health-related quality of life. Int J Dermatol. 2002;41:151-8.
35. Osman LM, Calder C, Robertson R, Friend JA, Legge JS, Douglas JG. Symptoms, quality of life, and health service contact among young adults with mild asthma. Am J Respir Crit Care Med. 2000;161 (2 Pt 1):498-503.
36. Laforest L, Bousquet J, Neukirch F, Aubier M, Pietri G, Devouassoux G, Pacheco Y, Van Ganse E. Influence of sociodemographic factors on quality of life during pollen season in seasonal allergic rhinitis patients. Ann Allergy Asthma Immunol. 2005;95:26-32.
37. De la Hoz B, Colás C, Rodríguez Rodríguez M, Grupo Freedom. Quality of life in patients with allergic rhinitis: comparative study with hypertension in primary care. An Sist Sanit Navar. 2009;32(2):169-81.
38. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use (2nd ed). Oxford: Oxford University Press, 1995.
39. Lohr KN, Aaronson NK, Alonso J, Burnam MA, Patrick DL, Perrin EB, Roberts JS. Evaluating quality-of-life and health status instruments: development of scientifi c review criteria. Clin Ther. 1996;18:979-92.
40. ESPRINT Study Group and Investigators, Valero A, Alonso J, Antepara I, Baró E, Colas C, del Cuvillo A, Ferrer M, Herdman M, Martí-Guadaño E, Monclús L, Mullol J, Navarro-Pulido AM, Navas C, Sastre J, Baltasar M, Bartra J, Serrano C, Cardona V, Castillo JA, Cerda MT, Cistero A, Conejero A, Davila I, Escudero C, Hernandez E, Vereda A, Fernandez B, Mencia J, Fernández J, Florido J, Quiralte J, Guardia P, Malek T, Montoro J, Orta JC, Oehling A, Pascual MJ, de la Parte B, Raga E, Rubira N, Ranea S, Rivas P, Serra J, Tabar A. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: The ESPRINT Questionnaire. Value Health. 2007;10(6):466-77.
41. Leong KP, Yeak SPL, Saurajen ASM, Mok PKH, Earnest A, Siow JK, Chee N WC, Yeo SB, Khoo ML, Lee JCY, Seshadr Ri, Chan SP, Tang CY. Why generic and disease-specifi c quality-oflife instruments should be used together for the evaluation of patients with persistent allergic rhinitis. Clin Exp Allergy. 2005;35:288-98.